REGENXBIO Announces Pricing of Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
REGENXBIO (RGNX) IPO Opens Up 38%
September 17, 2015 11:06 AM EDTToday's IPO for REGENXBIO Inc. (NASDAQ: RGNX) opened for trading at $30.26 after pricing 6,300,000 shares of its common stock at a public offering price of $22.00 per share, inline with the expected pricing. The number of shares offered was raised from 5,555,555 shares.
In addition, REGENXBIO granted the underwriters a 30-day option... More
REGENXBIO (RGNX) IPO Prices In-Line at $22
September 17, 2015 7:32 AM EDTREGENXBIO Inc. (NASDAQ: RGNX) announced the pricing of its initial public offering of 6,300,000 shares of its common stock at a public offering price of $22.00 per share, inline with the expected pricing. The number of shares offered was raised from... More
